Tag: EMA bioequivalence

Age and Sex in Bioequivalence Studies: What Regulators Require Today

Modern bioequivalence studies must account for age and sex differences to ensure generic drugs work safely for everyone. Learn what the FDA, EMA, and other regulators require today-and why outdated study designs are no longer enough.